Increased serum prolactin pituitary reserve in patients with prostatic neoplasms.
Prolactin (PRL) pituitary reserve was measured in 8 patients with prostatic adenoma and 11 patients with prostatic carcinoma. The PRL reserve was significantly higher in these patients compared to an age-matched control group of 6 subjects. A possible role for PRL-inhibiting drugs in the management of oestrogen-resistant carcinomas of the prostate is suggested.
D000368:Aged; D006801:Humans; D008297:Male; D008875:Middle Aged; D011388:Prolactin / Q000097:blood* / Q000378:metabolism; D011470:Prostatic Hyperplasia / Q000097:blood* / Q000503:physiopathology; D011471:Prostatic Neoplasms / Q000097:blood* / Q000503:physiopathology; D013973:Thyrotropin-Releasing Hormone
D013973:Thyrotropin-Releasing Hormone; D011388:Prolactin